Zeidan Ryan 4
4 · Millendo Therapeutics, Inc. · Filed Mar 31, 2020
Insider Transaction Report
Form 4
Zeidan Ryan
Chief Development Officer
Transactions
- Award
Employee Stock Option (right to buy)
2020-03-28+15,000→ 15,000 totalExercise: $4.80Exp: 2030-03-27→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to this option shall vest on March 28, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.